Logo

Tests Detect Alzheimer’s Risks, but Should Patients Be Told?

Marjie Popkin thought she had chemo brain, that fuzzy-headed forgetful state that she figured was a result of her treatment for ovarian cancer. She was not thinking clearly — having trouble with numbers, forgetting things she had just heard.

Click Here to read full article.


Comments RSS Responses are currently closed, but you can trackback from your own site.

Comments are closed.